Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2022 PRIZE WINNERS

2022 Prize Winners

News

June 7, 2022
PRESS RELEASE: THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE AWARDS $4.2M TO SEVEN EMERGING TRAILBLAZERS IN CANCER RESEARCH

NEW YORK, JUNE 7, 2022 (Business Wire) – The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize, totaling $4.2 million, empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking. Recipients receive $200,000 per year for three years.

Over the past nine years, the Alliance has awarded over $35 million to 59 scientists at 12 institutions in New York, New Jersey, and Connecticut. With this funding, the recipients have contributed greatly to the New York City area’s growing biomedical research hub. In addition to funding, the Alliance provides Prize winners with opportunities to present their work to scientific and business audiences to encourage collaboration and help bridge the gap between academia and industry.

“Tackling the ‘frontline science’ of cancer research at record speeds demands the bold innovation and rigor embodied by this year’s cohort of Prize winners,” said The Pershing Square Foundation Trustee Neri Oxman. “Young investigators lead the way in asking hard questions that hold the greatest potential for transformative impact, and we remain committed to empowering their groundbreaking work.”

READ MORE

Events

June 8, 2022 
2022 PERSHING SQUARE SOHN PRIZE

On Wednesday, June 8 the Pershing Square Sohn Cancer Research Alliance held its 2022 Prize Dinner at Bar65 at the Rainbow Room in New York, awarding its 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research to seven early-career pioneers in cancer research in the greater New York City area.

The evening began with cocktails on the terrace, followed by a seated dinner. To start the dinner, Olivia Tournay Flatto, PhD, President of The Pershing Square Foundation and Co-founder and Executive Director of the Pershing Square Sohn Cancer Research Alliance gave introductory remarks. The special guest speaker for the evening was Scientific Review Council Member Ali Brivanlou, PhD, Robert & Harriet Heilbrunn Professor at The Rockefeller University, who gave a fascinating presentation on his work with embryonic stem cells, the innovations in this space, and the ethical considerations, followed by a provocative and stimulating Q&A session. After the entrée, Scientific Review Council Member Dave Tuveson, MD, PhD, Roy J. Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory, introduced the seven Pershing Square Sohn Prize winners with a special video and welcomed The Pershing Square Foundation Co-Trustees William Ackman and Neri Oxman to lead the award ceremony.  Prize Advisory Board 2022 Chair Jim Rothman, PhD, Sterling Professor of Cell Biology and Professor of Chemistry at Yale School of Medicine, gave concluding remarks.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation